Skip to main content
. 2021 Jun 30;26(10):1977–1985. doi: 10.1007/s10147-021-01973-1

Fig. 1.

Fig. 1

Study design. MTD was defined as the maximal dose level at which the incidence of dose-limiting toxicity did not exceed 33%. MTD maximum tolerated dose, PLD pegylated liposomal doxorubicin